Inventor · disambiguated record
G. Davis Harris, Jr.
Also filed as: HARRIS G DAVIS · HARRIS JR G DAVIS
19 granted patents·403 citations·filing 1996–2019
95Inventor score
Top patents by PatentIndex Score
19 records- 0197US6239161B1Method and compositions for inhibition of adaptor protein/tyrosine kinase interactionsSUGEN INC·Filed 2000·Granted May 29, 2001·54 cites·9 claims
- 0293US8106197B2Aminoheteroaryl compounds as protein kinase inhibitorsCUI JINGRONG JEAN·Filed 2006·Granted Jan 31, 2012·48 cites·11 claims
- 0392US7230098B2Aminoheteroaryl compounds as protein kinase inhibitorsSUGEN INC·Filed 2004·Granted Jun 12, 2007·73 cites·15 claims
- 0490US7186832B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Mar 6, 2007·32 cites·4 claims
- 0590US6689806B1Indolinone compounds as kinase inhibitorsSUGEN INC·Filed 2000·Granted Feb 10, 2004·29 cites·19 claims
- 0689US9856201B23,6-dichlorosalicylic acid compounds and related synthetic processesMONSANTO TECHNOLOGY LLC·Filed 2015·Granted Jan 2, 2018·3 cites·20 claims
- 0788US10519092B23,6-dichlorosalicylic acid compounds and related synthetic processesMONSANTO TECHNOLOGY LLC·Filed 2017·Granted Dec 31, 2019·2 cites·18 claims
- 0885US6706709B2Indolinone derivatives as protein kinase/phosphatase inhibitorsSUGEN INC·Filed 2001·Granted Mar 16, 2004·24 cites·8 claims
- 0985US6660763B2Bis-indolylquinone compoundsSUGEN INC·Filed 2000·Granted Dec 9, 2003·20 cites·4 claims
- 1085US5780496AMethod and compositions for inhibition of adaptor protein/tyrosine kinase interactionsSUGEN INC·Filed 1996·Granted Jul 14, 1998·24 cites·27 claims
- 1178US6080772AThiazole compounds and methods of modulating signal transductionSUGEN INC·Filed 1997·Granted Jun 27, 2000·22 cites·21 claims
- 1277US7157460B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Jan 2, 2007·8 cites·4 claims
- 1376US10807936B23,6-dichlorosalicylic acid compounds and related synthetic processesMONSANTO TECHNOLOGY LLC·Filed 2019·Granted Oct 20, 2020·0 cites·11 claims
- 1476US5786488ASynthetic methods for the preparation of indolyquinonesSUGEN INC·Filed 1997·Granted Jul 28, 1998·30 cites·30 claims
- 1572US6376529B1Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereofFiled 1999·Granted Apr 23, 2002·30 cites·34 claims
- 1665US7071332B2Indolinone derivatives as protein kinase/phosphatase inhibitorsSUGEN INC·Filed 2003·Granted Jul 4, 2006·2 cites·7 claims
- 1756US6750240B2Methods of using bis-indolylquinonesSUGEN INC·Filed 2000·Granted Jun 15, 2004·0 cites·1 claims
- 1837US6110957ASynthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefromSUGEN INC·Filed 1998·Granted Aug 29, 2000·2 cites·6 claims
- 1933US6090838AMethods and compositions for inhibition of adaptor protein/tyrosine kinase interactionsSUGEN INC·Filed 1998·Granted Jul 18, 2000·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when G. Davis Harris, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →